The Conversation (0)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Johnson & Johnson ('J&J" or 'the Company') (NYSE:JNJ). Investors who purchased J&J shares are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.comJNJ
The investigation concerns whether J&J and certain of its officers and/or directors have violated federal securities laws.
On July 14, 2021, J&J issued a voluntary recall of all lots of five of the Company's Neutrogena and Aveeno aerosol sunscreen product lines, after "[i]nternal testing identified low levels of benzene"-a substance classified as a carcinogen-"in some samples of the products". On this news, J&J's stock price fell sharply during intraday trading on July 15, 2021.
If you are aware of any facts relating to this investigation, or purchased J&J shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/jnj. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View source version on accesswire.com:
https://www.accesswire.com/655717/Bronstein-Gewirtz-Grossman-LLC-Notifies-Shareholders-of-Johnson-Johnson-JNJ-Investigation
